Directory › Almac

Almac — Craigavon

Craigavon, United Kingdom · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Almac
Name(s) in FDA data
Almac Sciences Limited
FEI number(s)
3008699637 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Craigavon, United Kingdom
Records matched
5 FDA inspections
Most recent FDA inspection in dataset
08 May 2025 — NAI

Capabilities (from the company's website)

  • Small molecule
    …raigavon facilities provide integrated development and GMP manufacturing capabilities for small molecules, highly potent compounds and peptides. Capabilities include: Laboratory reactors from 250…
  • API / drug substance (chemical)
    …Craigavon, UK: API Development & GMP Manufacture Our Craigavon facilities provide integrated development and…
  • Highly potent (HPAPI)
    …es provide integrated development and GMP manufacturing capabilities for small molecules, highly potent compounds and peptides. Capabilities include: Laboratory reactors from 250 mL to 20 L Kil…
  • Peptides & oligonucleotides
    …pment and GMP manufacturing capabilities for small molecules, highly potent compounds and peptides. Capabilities include: Laboratory reactors from 250 mL to 20 L Kilo laboratory infrastruc…

Taken from the part of the company's network/locations page that describes this site. Source: https://www.almacgroup.com/api-chemical-development/late-phase-api-development-and-manufacture/api-manufacturing-facilities, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 08 May 2025
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3008699637, inspection ID 1288202)

  2. 13 Sep 2019
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3008699637, inspection ID 1101915)

  3. 28 Apr 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3008699637, inspection ID 977687)

  4. 05 Dec 2014
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3008699637, inspection ID 905276)

  5. 22 Feb 2012
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3008699637, inspection ID 774198)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.